0.5%马来酸噻吗洛尔溶液联合普萘洛尔治疗婴幼儿血管瘤的不良反应观察

中国口腔颌面外科杂志 ›› 2014, Vol. 12 ›› Issue (6): 539-542.

0.5%马来酸噻吗洛尔溶液联合普萘洛尔治疗婴幼儿血管瘤的不良反应观察

王佳, 石静, 王绪凯

中国医科大学附属口腔医院口腔颌面外科,辽宁省口腔医学研究所,辽宁沈阳 110002

收稿日期:2014-04-24 出版日期:2014-11-10 发布日期:2015-01-01
通讯作者: 王佳,E-mail：369337521@qq.com
作者简介:王佳 (1983-),女, 护师

Adverse effects of timolol maleate 0.5% solution combined with propranolol in treating infantile hemangiomas

WANG Jia, SHI Jing, WANG Xu-kai

Department of Oral and Maxillofacial Surgery, School of Stomatology, China Medical University,Liaoning Institute of Dental Research. Shenyang 110002, Liaoning Province, China

Received:2014-04-24 Online:2014-11-10 Published:2015-01-01

摘要/Abstract

摘要： 目的局部涂抹0.5%马来酸噻吗洛尔溶液联合口服普萘洛尔与单纯口服普萘洛尔治疗婴幼儿血管瘤60例,评价其近期效果及不良反应。方法随机抽取局部涂抹0.5%马来酸噻吗洛尔溶液联合口服普萘洛尔的患儿及单纯口服普萘洛尔治疗血管瘤的患儿各30例,用药前检查结果无异常,用药前、后1 h观察其心率、血压变化;服药后1个月观察有无呕吐、嗜睡、腹泻、局部皮肤反应、肢端发冷及低血糖症状等。采用SPSS 13.0软件包对数据进行统计学处理。结果 2组不良反应例数无显著差异,用药前、后1h内血压、心率变化不明显。结论局部涂抹0.5%马来酸噻吗洛尔溶液联合口服普萘洛尔与单纯口服普萘洛尔的近期不良反应发生率相近,无严重不良反应发生。

关键词: 婴幼儿血管瘤, 马来酸噻吗洛尔, 普萘洛尔, 不良反应

Abstract: PURPOSE : To observe the adverse effects of using topical timolol maleate 0.5% solution in combination with oral propranolol and oral propranolol alone for infantile hemangiomas (IH). METHODS : A total of 60 infants with IH were included in this study, in which 30 patients were treated with topical timolol maleate 0.5% solution combined with oral propranolol and the remaining 30 cases received oral propranolol alone. All patients showed no abnormalities on physical examination before the treatment. The changes of heart rate and blood pressure were monitored before and 1h after treatment. Potential side effects such as vomiting, lethargy, diarrhea, local skin reactions, cold extremities, and hypoglycemia were observed and recorded 1-month after treatment. The data was statistically analyzed with SPSS13.0 software package. RESULTS : There was no significant difference in adverse effects between the 2 groups and the difference was not significant in heart rate and blood pressure before and 1 h after treatment. CONCLUSIONS : The adverse reactions were similar between patients receiving topical timolol maleate 0.5% solution in combination with oral propranolol and oral propranolol alone, no serious adverse events were found.

Key words: Infantile hemangioma, Timolol maleate, Propranolol, Adverse effects

中图分类号:

R739.8

王佳, 石静, 王绪凯. 0.5%马来酸噻吗洛尔溶液联合普萘洛尔治疗婴幼儿血管瘤的不良反应观察[J]. 中国口腔颌面外科杂志, 2014, 12(6): 539-542.

WANG Jia, SHI Jing, WANG Xu-kai. Adverse effects of timolol maleate 0.5% solution combined with propranolol in treating infantile hemangiomas[J]. China J Oral Maxillofac Surg, 2014, 12(6): 539-542.

参考文献

[1] Chang EI, Chang EI, Thangarajah H, et a1. Hypoxia, hormones, and endothelial progenitor cells in hemangioma [J]. Lymphat Res Biol, 2007, 5(4): 237-243.
[2] 金云波, 林晓曦, 叶肖肖, 等. 普萘洛尔作为严重婴幼儿血管瘤一线治疗的前瞻性研究[J]. 中华整形外科杂志, 201l, 27(3): 170-173.
[3] 叶肖肖, 金云波, 林晓曦, 等. 外用马来酸噻吗洛尔治疗婴幼儿眼周浅表血管瘤的前瞻性研究[J]. 中华整形外科杂志, 2011, 28(3): 161-162.
[4] Schiestl C, Neuhaus K, Zoller S, et al. Efficacy and safety of propranolol as first-line treatment for infantile hemangiomas [J]. Eur J Pediatr, 2011, 170(4): 493-501.
[5] Li YC, McCahon E, Rowe NA, et al. Successful treatment of infantile haemangiomas of the orbit with propranolol[J]. Clin Experiment Ophthalmol, 2010, 38(6): 554-559.
[6] Fridman G, Grieser E, Hill R, et al. Propranolol for the treatment of orbital infantile hemangiomas[J]. Ophthal Plast Reconstr Surg, 2011, 27(3): 190-194.
[7] Cheng JF, Gole GA, Sullivan TJ. Propranolol in the management of periorbital infantile haemangioma[J]. Clin Exp Ophthalmol, 2010, 38(6):547-553.
[8] Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using β-blocker solution[J]. Arch Ophthalmol,2010,128(2): 255-256.
[9] Moehrle M, Léauté-Labrèze C, Schmidt V, et a1. Topical timolol for small hemangiomas of infancy[J]. Pediatr Dermatol,2013,30(2): 245-249.
[10] Semkova K, Kazandjieva J. Topical timolol maleate for treatment of infantile haemangiomas: preliminary results of a prospective study [J]. Clin Exp Dermatol, 2013, 38(2): 143-146.
[11] 钱厚海, 梁贵健, 朱莉, 等. 马来酸噻吗洛尔滴眼液的HPLC测定 [J]. 中国医药工业杂志, 1995, 26(5): 209-210.
[12] Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action [J]. Br J Dermatol, 2010, 163(2): 269-274.
[13] Coppens G, Stalmans I, Zeyen T, et al. The safety and efficacy of glaucoma medication in the pediatric population [J]. J Pediatr Ophthalmol Strabismus, 2009, 46(1): 12-18.
[14] Khunger N, Pahwa M. Dramatic response to topical timolol lotion of a large hemifacial infantile haemangioma associated with PHACE syndrome [J]. Br J Dermatol, 2011, 164(4): 886-888.
[15] McMahon P, Oza V, Frieden IJ. Topical timolol for infantile hemangiomas: putting a note of caution in "cautiously optimistic" [J]. Pediatr Dermatol, 2012, 29(1): 127-130.
[16] Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis[J]. N Engl J Med, 1995, 333(26): 1757-1763.
[17] Zhou HH, Koshakji RP, Silberstein DJ, et al. Altered sensitivity to and clearance of propranolol in men of Chinese descent as compared with American whites [J]. N Engl J Med, 1989, 320(9): 565-570.